P16INK4a protein expression is associated with poor survival of the breast cancer patients after CMF chemotherapy. (Q43862141)
Jump to navigation
Jump to search
scientific article published in December 2001
Language | Label | Description | Also known as |
---|---|---|---|
English | P16INK4a protein expression is associated with poor survival of the breast cancer patients after CMF chemotherapy. |
scientific article published in December 2001 |
Statements
P16INK4a protein expression is associated with poor survival of the breast cancer patients after CMF chemotherapy (English)
S H Ahn
K Park
B N Bae
K H Kim
H J Kim
Y D Kim
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference